Latest News
Investing in quality businesses is key.
Via The Motley Fool · December 31, 2025
If you're thinking about claiming Social Security in 2026, you need a solid strategy to make sure you're optimizing your benefits.
Via The Motley Fool · December 31, 2025
Millionaires live below their means, build income streams, and invest like clockwork. Here's how to copy the habits that build real wealth.
Via The Motley Fool · December 31, 2025
Via MarketBeat · December 31, 2025
Pricing is not the only issue for Beyond Meat.
Via The Motley Fool · December 31, 2025
H&R BLOCK INC (NYSE:HRB) Offers a High, Sustainable Yield Backed by Strong Profitabilitychartmill.com
Via Chartmill · December 31, 2025
Jack Henry & Associates Inc. (NASDAQ:JKHY): A Quality Dividend Stock for Long-Term Incomechartmill.com
Via Chartmill · December 31, 2025
NetEase Inc-ADR (NASDAQ:NTES) Passes Key Quality Investing Screenchartmill.com
Via Chartmill · December 31, 2025
Upstart has been a very volatile stock to own, while American Express trades near record territory.
Via The Motley Fool · December 31, 2025
Social Security's work rules are changing in 2026, and the news isn't all good.
Via The Motley Fool · December 31, 2025
These stocks have increased dividends annually for more than half a century.
Via The Motley Fool · December 31, 2025
Political upheaval is spreading and intensifying, maybe presenting an opportunity, but either way, it is, by far, the greatest risk the world faces in 2026.
Via Talk Markets · December 31, 2025
Lululemon’s net revenue from the U.S. region fell 2% in its Q3 earnings due to slowing consumer demand amid macro uncertainties.
Via Stocktwits · December 31, 2025
Taylor Morrison Home Corp (NYSE:TMHC) Emerges as a 'Decent Value' Investment Candidatechartmill.com
Via Chartmill · December 31, 2025
EUR/USD extends losses for the sixth consecutive day, nearing 1.1700.
Via Talk Markets · December 31, 2025
AXS-12 is being developed to treat cataplexy in narcolepsy by targeting norepinephrine and dopamine activity in the brain.
Via Stocktwits · December 31, 2025
Here are three stocks -- including a turnaround, a growth story, and a high-yield play -- that investors will want to dig into this new year.
Via The Motley Fool · December 31, 2025
XPeng was the top performer in 2025, with gains of around 80%, while Li Auto’s stock declined 28% YTD.
Via Stocktwits · December 31, 2025
Nvidia licenses Groq's inference chip technology to improve its AI solutions.
Via The Motley Fool · December 31, 2025
GENMAB A/S -SP ADR (NASDAQ:GMAB) Passes Peter Lynch's GARP Investment Screenchartmill.com
Via Chartmill · December 31, 2025
Ethan Choi, a partner at the Menlo Park-based firm Khosla Ventures, shared his predictions for 2026 in an interview with Business Insider.
Via Stocktwits · December 31, 2025
Drugmakers are outlining 2026 list price changes, with most adjustments typically announced in January.
Via Stocktwits · December 31, 2025
Decades ago, the mainstream media wondered how much longer Nike's party could last.
Via The Motley Fool · December 31, 2025
JFrog’s stock has outperformed most high-profile AI names, supported by a strong technical setup and the company’s improving growth profile.
Via Stocktwits · December 31, 2025
OpenAI has been tight-lipped about its forthcoming AI device.
Via Stocktwits · December 31, 2025